Bromine in PDB 1m9r: Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
Enzymatic activity of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
All present enzymatic activity of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound:
1.14.13.39;
Protein crystallography data
The structure of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound, PDB code: 1m9r
was solved by
R.J.Rosenfeld,
E.D.Garcin,
K.Panda,
G.Andersson,
A.Aberg,
A.V.Wallace,
D.J.Stuehr,
J.A.Tainer,
E.D.Getzoff,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.65 /
2.56
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
68.625,
90.280,
155.490,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.8 /
26.6
|
Other elements in 1m9r:
The structure of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
(pdb code 1m9r). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the
Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound, PDB code: 1m9r:
Jump to Bromine binding site number:
1;
2;
3;
4;
Bromine binding site 1 out
of 4 in 1m9r
Go back to
Bromine Binding Sites List in 1m9r
Bromine binding site 1 out
of 4 in the Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br906
b:45.0
occ:1.00
|
BR
|
A:INE906
|
0.0
|
45.0
|
1.0
|
C3
|
A:INE906
|
1.8
|
44.8
|
1.0
|
N2
|
A:INE906
|
2.8
|
45.3
|
1.0
|
C9
|
A:INE906
|
2.9
|
44.8
|
1.0
|
C1C
|
A:HEM901
|
3.5
|
37.6
|
1.0
|
C4
|
A:INE906
|
3.5
|
45.0
|
1.0
|
CD1
|
A:PHE353
|
3.5
|
36.3
|
1.0
|
CA
|
A:SER354
|
3.6
|
33.9
|
1.0
|
NC
|
A:HEM901
|
3.6
|
37.6
|
1.0
|
O
|
A:PRO334
|
3.7
|
34.2
|
1.0
|
N
|
A:GLY355
|
3.7
|
34.9
|
1.0
|
CE1
|
A:PHE353
|
3.8
|
36.1
|
1.0
|
C2C
|
A:HEM901
|
3.8
|
38.5
|
1.0
|
O
|
A:PHE353
|
3.8
|
36.9
|
1.0
|
C
|
A:SER354
|
3.9
|
34.6
|
1.0
|
CHC
|
A:HEM901
|
3.9
|
37.6
|
1.0
|
N1
|
A:INE906
|
3.9
|
44.2
|
1.0
|
C4C
|
A:HEM901
|
4.0
|
38.7
|
1.0
|
C8
|
A:INE906
|
4.0
|
44.0
|
1.0
|
N
|
A:SER354
|
4.1
|
35.2
|
1.0
|
C3C
|
A:HEM901
|
4.1
|
39.5
|
1.0
|
C
|
A:PHE353
|
4.2
|
36.0
|
1.0
|
CG2
|
A:VAL336
|
4.2
|
32.5
|
1.0
|
CMC
|
A:HEM901
|
4.4
|
36.6
|
1.0
|
C4B
|
A:HEM901
|
4.5
|
38.0
|
1.0
|
N
|
A:VAL336
|
4.5
|
36.1
|
1.0
|
CHD
|
A:HEM901
|
4.7
|
40.9
|
1.0
|
C
|
A:PRO334
|
4.7
|
34.5
|
1.0
|
FE
|
A:HEM901
|
4.7
|
36.7
|
1.0
|
CA
|
A:GLY355
|
4.7
|
35.0
|
1.0
|
NB
|
A:HEM901
|
4.7
|
39.2
|
1.0
|
CG
|
A:PHE353
|
4.7
|
34.3
|
1.0
|
CB
|
A:SER354
|
4.7
|
34.1
|
1.0
|
O
|
A:SER354
|
4.9
|
35.6
|
1.0
|
CB
|
A:VAL336
|
4.9
|
36.3
|
1.0
|
CA
|
A:ALA335
|
4.9
|
33.5
|
1.0
|
C5
|
A:INE906
|
4.9
|
44.3
|
1.0
|
|
Bromine binding site 2 out
of 4 in 1m9r
Go back to
Bromine Binding Sites List in 1m9r
Bromine binding site 2 out
of 4 in the Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br903
b:74.0
occ:0.90
|
BR
|
A:INE903
|
0.0
|
74.0
|
0.9
|
C3
|
A:INE903
|
1.7
|
70.4
|
0.9
|
N2
|
A:INE903
|
2.8
|
70.3
|
0.9
|
C9
|
A:INE903
|
2.9
|
68.1
|
0.9
|
C4
|
A:INE903
|
3.5
|
66.0
|
0.9
|
NE1
|
B:TRP447
|
3.5
|
43.0
|
1.0
|
CD1
|
B:TRP447
|
3.5
|
41.9
|
1.0
|
NH1
|
B:ARG365
|
3.8
|
52.5
|
1.0
|
CE2
|
B:TRP447
|
3.8
|
42.2
|
1.0
|
CG
|
B:TRP447
|
3.9
|
41.7
|
1.0
|
N1
|
A:INE903
|
3.9
|
67.8
|
0.9
|
O
|
B:ALA446
|
4.0
|
35.9
|
1.0
|
CD2
|
B:TRP447
|
4.0
|
43.5
|
1.0
|
C8
|
A:INE903
|
4.1
|
66.0
|
0.9
|
CZ
|
A:PHE460
|
4.2
|
43.9
|
1.0
|
CE1
|
A:PHE460
|
4.3
|
45.0
|
1.0
|
CA
|
B:TRP447
|
4.3
|
35.6
|
1.0
|
O
|
B:HOH630
|
4.4
|
52.5
|
1.0
|
CZ2
|
B:TRP447
|
4.6
|
46.5
|
1.0
|
CB
|
B:TRP447
|
4.6
|
36.9
|
1.0
|
C
|
B:ALA446
|
4.7
|
36.2
|
1.0
|
N
|
B:TRP447
|
4.9
|
35.6
|
1.0
|
C5
|
A:INE903
|
4.9
|
66.0
|
0.9
|
CZ
|
B:ARG365
|
4.9
|
50.2
|
1.0
|
CE3
|
B:TRP447
|
4.9
|
46.3
|
1.0
|
|
Bromine binding site 3 out
of 4 in 1m9r
Go back to
Bromine Binding Sites List in 1m9r
Bromine binding site 3 out
of 4 in the Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br907
b:47.7
occ:1.00
|
BR
|
B:INE907
|
0.0
|
47.7
|
1.0
|
C3
|
B:INE907
|
1.8
|
44.4
|
1.0
|
N2
|
B:INE907
|
2.8
|
42.9
|
1.0
|
C9
|
B:INE907
|
2.9
|
44.4
|
1.0
|
CD1
|
B:PHE353
|
3.3
|
35.2
|
1.0
|
C4
|
B:INE907
|
3.5
|
43.9
|
1.0
|
C1C
|
B:HEM901
|
3.5
|
33.5
|
1.0
|
CA
|
B:SER354
|
3.5
|
32.5
|
1.0
|
CE1
|
B:PHE353
|
3.6
|
35.4
|
1.0
|
O
|
B:PRO334
|
3.6
|
38.6
|
1.0
|
NC
|
B:HEM901
|
3.7
|
33.8
|
1.0
|
O
|
B:PHE353
|
3.7
|
33.0
|
1.0
|
C2C
|
B:HEM901
|
3.8
|
33.9
|
1.0
|
N
|
B:GLY355
|
3.8
|
33.0
|
1.0
|
N1
|
B:INE907
|
3.9
|
43.6
|
1.0
|
C
|
B:SER354
|
3.9
|
33.3
|
1.0
|
CHC
|
B:HEM901
|
4.0
|
33.5
|
1.0
|
C4C
|
B:HEM901
|
4.0
|
33.0
|
1.0
|
N
|
B:SER354
|
4.0
|
32.7
|
1.0
|
C8
|
B:INE907
|
4.0
|
43.7
|
1.0
|
C
|
B:PHE353
|
4.1
|
33.7
|
1.0
|
C3C
|
B:HEM901
|
4.1
|
33.1
|
1.0
|
CMC
|
B:HEM901
|
4.4
|
35.1
|
1.0
|
CG2
|
B:VAL336
|
4.5
|
39.3
|
1.0
|
C4B
|
B:HEM901
|
4.6
|
32.2
|
1.0
|
CG
|
B:PHE353
|
4.6
|
35.0
|
1.0
|
C
|
B:PRO334
|
4.6
|
39.2
|
1.0
|
N
|
B:VAL336
|
4.7
|
40.5
|
1.0
|
CHD
|
B:HEM901
|
4.7
|
35.1
|
1.0
|
CB
|
B:SER354
|
4.7
|
31.1
|
1.0
|
NB
|
B:HEM901
|
4.8
|
32.6
|
1.0
|
CA
|
B:GLY355
|
4.8
|
31.6
|
1.0
|
FE
|
B:HEM901
|
4.9
|
31.9
|
1.0
|
O
|
B:SER354
|
4.9
|
33.5
|
1.0
|
C5
|
B:INE907
|
4.9
|
46.0
|
1.0
|
CZ
|
B:PHE353
|
4.9
|
35.5
|
1.0
|
CAC
|
B:HEM901
|
5.0
|
31.9
|
1.0
|
|
Bromine binding site 4 out
of 4 in 1m9r
Go back to
Bromine Binding Sites List in 1m9r
Bromine binding site 4 out
of 4 in the Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human Endothelial Nitric Oxide Synthase with 3-Bromo-7- Nitroindazole Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Br902
b:60.3
occ:0.80
|
BR
|
B:INE902
|
0.0
|
60.3
|
0.8
|
C3
|
B:INE902
|
1.7
|
59.8
|
0.8
|
N2
|
B:INE902
|
2.8
|
59.5
|
0.8
|
C9
|
B:INE902
|
2.9
|
57.8
|
0.8
|
C4
|
B:INE902
|
3.4
|
58.1
|
0.8
|
NH2
|
A:ARG365
|
3.5
|
47.0
|
1.0
|
NE1
|
A:TRP447
|
3.6
|
55.4
|
1.0
|
CD1
|
A:TRP447
|
3.6
|
53.1
|
1.0
|
CE2
|
A:TRP447
|
3.8
|
55.2
|
1.0
|
CG
|
A:TRP447
|
3.9
|
51.2
|
1.0
|
N1
|
B:INE902
|
3.9
|
58.6
|
0.8
|
O
|
A:HOH729
|
3.9
|
30.0
|
1.0
|
CZ
|
B:PHE460
|
4.0
|
31.6
|
1.0
|
C8
|
B:INE902
|
4.0
|
57.5
|
0.8
|
CD2
|
A:TRP447
|
4.1
|
52.6
|
1.0
|
O
|
A:ALA446
|
4.2
|
36.6
|
1.0
|
CE1
|
B:PHE460
|
4.3
|
33.0
|
1.0
|
CZ
|
A:ARG365
|
4.4
|
43.0
|
1.0
|
CA
|
A:TRP447
|
4.5
|
42.2
|
1.0
|
NE
|
A:ARG365
|
4.5
|
42.4
|
1.0
|
CZ2
|
A:TRP447
|
4.5
|
57.2
|
1.0
|
CB
|
A:TRP447
|
4.8
|
45.3
|
1.0
|
C5
|
B:INE902
|
4.8
|
59.7
|
0.8
|
CE3
|
A:TRP447
|
4.9
|
55.5
|
1.0
|
C
|
A:ALA446
|
4.9
|
39.7
|
1.0
|
|
Reference:
R.J.Rosenfeld,
E.D.Garcin,
K.Panda,
G.Andersson,
A.Aberg,
A.V.Wallace,
G.M.Morris,
A.J.Olson,
D.J.Stuehr,
J.A.Tainer,
E.D.Getzoff.
Conformational Changes in Nitric Oxide Synthases Induced By Chlorzoxazone and Nitroindazoles: Crystallographic and Computational Analyses of Inhibitor Potency Biochemistry V. 41 13915 2002.
ISSN: ISSN 0006-2960
PubMed: 12437348
DOI: 10.1021/BI026313J
Page generated: Wed Jul 10 16:53:34 2024
|